Celularity Inc. Form 8-K Summary
Business Context and Reporting Period
Celularity Inc. filed a Form 8-K relating to its failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2023. The report identifies April 17, 2024 as the date of the earliest event reported and was signed on April 22, 2024.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics. It states that Celularity had not completed preparation of its financial statements for the year ended December 31, 2023.
Material Changes Versus the Prior Comparable Period
- Celularity did not file its 2023 Form 10-K by the extended deadline available under Rule 12b-25, which expired on April 15, 2024.
- On April 17, 2024, Nasdaq notified Celularity that it was not compliant with Nasdaq Listing Rule 5250(c)(1), concerning timely filing of required periodic reports.
- Celularity’s Class A common stock and warrants continued to trade on the Nasdaq Capital Market under the symbols CELU and CELUW; the notice had no immediate effect on their listing.
Outlook, Risks, Contingencies, and Unusual Items
- Celularity must submit a plan to regain Nasdaq compliance by June 17, 2024.
- If Nasdaq accepts the plan, the company may have until October 14, 2024, described as 180 calendar days from the Form 10-K due date, to implement it.
- Celularity stated that it intends to submit a compliance plan and evaluate available options, but provided no assurance that it will regain or maintain compliance.
- Nasdaq may initiate delisting proceedings if it determines that Celularity cannot cure the deficiency or is otherwise ineligible.
Important Facts for Investors to Verify
- The actual filing date and status of Celularity’s 2023 Form 10-K and related financial statements.
- Whether Nasdaq accepted the company’s compliance plan and any subsequent compliance deadlines or determinations.
- Whether trading of CELU and CELUW remains on Nasdaq and whether any delisting notice or appeal process has commenced.
- The company’s financial condition, liquidity, debt obligations, and audit status once the 2023 Form 10-K is filed.